SCHEMBL7067709

SCHEMBL7067709

CCCCC(=O)C(Cc1ccccc1OCc1cnc2ccccc2c1)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
PDE10A Q9Y233 5/20 0.41
TRPV1 Q8NER1 6/20 0.40
CCKBR P32239 1/20 0.38
MME P08473 1/20 0.38
ACE P12821 1/20 0.38
CPA1 P15085 1/20 0.38
ACE2 Q9BYF1 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7072255 0.94 PDE10A (0.43) MEN1KMT2APDE10ATRPV1CCKBR
SCHEMBL7065961 0.90 MME (0.40) MEN1KMT2APDE10ATRPV1MME
SCHEMBL7604848 0.88 MGAM (0.43) PDE10AMMEACECPA1ACE2
SCHEMBL7066080 0.86 SMN1; SMN2 (0.41) KMT2APDE10AMMEACECPA1
SCHEMBL7067707 0.85 CYSLTR2 (0.46) MEN1KMT2ATRPV1CCKBR
SCHEMBL7069548 0.83 PDE10A (0.42) MEN1KMT2APDE10ASCN9ASIRT2
SCHEMBL7069255 0.82 MME (0.39) KMT2APDE10AMMEACECPA1
SCHEMBL7067698 0.82 TRPV1 (0.43) MEN1KMT2APDE10ATRPV1CCKBR
SCHEMBL7068926 0.82 TRPV1 (0.43) MEN1KMT2APDE10ATRPV1CCKBR
SCHEMBL7069697 0.81 PPARG (0.41) MEN1KMT2APDE10ATRPV1CCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030212100-A1 Quinoline derivatives and medicinal use thereof MITSUI CHEMICALS, INC. (JP) 2003-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212100-A1 Quinoline derivatives and medicinal use thereof PPARG, PPARD, PPARA MEN1 4618/4885KMT2A 2329/4885PDE10A 2389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.